GNA Biosolutions Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 39

Employees

  • Latest Deal Type
  • M&A

GNA Biosolutions General Information

Description

Manufacturer of molecular diagnostic devices intended to detect and analyze deoxyribonucleic acid (DNA). The company's device uses a pulse-controlled amplification technology to feature nucleic acid amplification and detection with fast heating and cooling rates, enabling laboratories to diagnose and amplify human pathogens and deoxyribonucleic acid (DNA) in an efficient and simplified way.

Contact Information

Website
www.gna-bio.com
Formerly Known As
Nanostove Project
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Am Klopferspitz 19
  • Martinsried, Planegg
  • 82152 Munich
  • Germany
+49 089
Primary Industry
Diagnostic Equipment
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Am Klopferspitz 19
  • Martinsried, Planegg
  • 82152 Munich
  • Germany
+49 089

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GNA Biosolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 05-Feb-2021 Completed Generating Revenue
6. Later Stage VC (Series C) 30-Aug-2019 Completed Generating Revenue
5. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
4. Later Stage VC (Series B) 19-Jun-2015 Completed Startup
3. Early Stage VC (Series A) 20-Dec-2012 Completed Startup
2. Early Stage VC 14-Mar-2011 Completed Startup
1. Spin-Off 01-Jan-2010 Completed Startup
To view GNA Biosolutions’s complete valuation and funding history, request access »

GNA Biosolutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of molecular diagnostic devices intended to detect and analyze deoxyribonucleic acid (DNA). The company's d
Diagnostic Equipment
Munich, Germany
39 As of 2024

London, United Kingdom
 

Frederick, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GNA Biosolutions Competitors (13)

One of GNA Biosolutions’s 13 competitors is DNAe, a Formerly VC-backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAe Formerly VC-backed London, United Kingdom
Akonni Biosystems Venture Capital-Backed Frederick, MD
Covaris Private Equity-Backed Woburn, MA
SQI Diagnostics Corporation Toronto, Canada
LEX Diagnostics Corporate Backed or Acquired Melbourn, United Kingdom
You’re viewing 5 of 13 competitors. Get the full list »

GNA Biosolutions Patents

  • 51

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • Pending

  • Expiring in next 12 mo

GNA Biosolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021259960-A1 Method and device for extracting and/or amplifying a target nucleic acid Inactive 26-Jun-2020
WO-2020225286-A1 Method and device for extracting and/or reproducing a target nucleic acid Inactive 07-May-2019
WO-2020225286-A9 Method and device for extracting and/or reproducing a target nucleic acid Inactive 07-May-2019
WO-2019158417-A1 Method and device for extracting a nucleic acid from a sample liquid Inactive 13-Feb-2018
DE-102017123919-A1 Method and apparatus for lysing microorganisms Inactive 13-Oct-2017 C12N1/066
To view GNA Biosolutions’s complete patent history, request access »

GNA Biosolutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GNA Biosolutions Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayern Kapital Venture Capital Minority
Bosch Ventures Corporate Venture Capital Minority
GreyBird Ventures Venture Capital Minority
Inovis Corporation Minority
KfW Group Investment Bank Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

GNA Biosolutions FAQs

  • When was GNA Biosolutions founded?

    GNA Biosolutions was founded in 2010.

  • Where is GNA Biosolutions headquartered?

    GNA Biosolutions is headquartered in Munich, Germany.

  • What is the size of GNA Biosolutions?

    GNA Biosolutions has 39 total employees.

  • What industry is GNA Biosolutions in?

    GNA Biosolutions’s primary industry is Diagnostic Equipment.

  • Is GNA Biosolutions a private or public company?

    GNA Biosolutions is a Private company.

  • What is GNA Biosolutions’s current revenue?

    The current revenue for GNA Biosolutions is .

  • How much funding has GNA Biosolutions raised over time?

    GNA Biosolutions has raised $20.2M.

  • Who are GNA Biosolutions’s investors?

    Bayern Kapital, Bosch Ventures, GreyBird Ventures, Inovis, and KfW Group are 5 of 14 investors who have invested in GNA Biosolutions.

  • Who are GNA Biosolutions’s competitors?

    DNAe, Akonni Biosystems, Covaris, SQI Diagnostics, and LEX Diagnostics are some of the 13 competitors of GNA Biosolutions.

  • When was GNA Biosolutions acquired?

    GNA Biosolutions was acquired on 05-Feb-2021.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process